ÂÜÀòÂÒÂ×

Virginia Ojeda Seijas, PhD, currently serves as the Respiratory and Immunology CI Director at AstraZeneca since September 2024. Prior experience includes roles as a Scientific Advisor at BioExpert Network and Global Senior Project Lead at Fenix Group International, LLC, where Virginia contributed to market analytics and strategy in the life sciences sector. A background in oncology research was furthered through positions at Rare Genomics Institute and Memorial Sloan Kettering Cancer Center. Virginia obtained a PhD in Molecular Biology from Universidad de Salamanca and possesses multiple advanced degrees, including a Master's in Pharmaceutical Marketing and additional training in leadership and scientific writing.